AC Immune SA (ACIU)
2.40
+0.11
(+4.80%)
USD |
NASDAQ |
Apr 26, 15:38
AC Immune Cash from Investing (TTM): 73.11M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.11M |
| September 30, 2023 | 53.42M |
| June 30, 2023 | 42.01M |
| March 31, 2023 | 71.72M |
| December 31, 2022 | 24.92M |
| September 30, 2022 | -4.452M |
| June 30, 2022 | 0.6043M |
| March 31, 2022 | -58.43M |
| December 31, 2021 | -58.72M |
| September 30, 2021 | -30.85M |
| June 30, 2021 | -14.08M |
| March 31, 2021 | 29.56M |
| December 31, 2020 | 30.22M |
| September 30, 2020 | 21.17M |
| June 30, 2020 | -6.848M |
| March 31, 2020 | -16.85M |
| December 31, 2019 | -67.32M |
| Date | Value |
|---|---|
| September 30, 2019 | -93.23M |
| June 30, 2019 | -81.86M |
| March 31, 2019 | -82.22M |
| December 31, 2018 | -32.75M |
| September 30, 2018 | -1.700M |
| June 30, 2018 | -1.876M |
| March 31, 2018 | -2.455M |
| December 31, 2017 | -1.87M |
| September 30, 2017 | -2.191M |
| June 30, 2017 | -2.184M |
| March 31, 2017 | -1.340M |
| December 31, 2016 | -0.9126M |
| September 30, 2016 | -0.6341M |
| June 30, 2016 | -0.4456M |
| March 31, 2016 | -0.3799M |
| December 31, 2015 | -0.2536M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-93.23M
Minimum
Sep 2019
73.11M
Maximum
Dec 2023
-4.522M
Average
-4.452M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
| Roche Holding AG | -12.00B |
| CRISPR Therapeutics AG | 374.65M |
| Addex Therapeutics Ltd | -0.0076M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 49.71M |